Clinical trial Recruiting at 4 sites Interventional Ages 55 and up

Walkasins to improve balance for people with peripheral neuropathy

Official title: Balance4Mobility: Effects of Walkasins Use on Clinical Outcomes of Gait and Balance Function in Individuals With Peripheral Neuropathy and Balance Problems - A Randomized Control Trial

Run by RxFunction Inc. · NCT06959277 · Data updated 2026-11-12

This project will test whether daily use of Walkasins helps people with peripheral neuropathy improve foot-placement awareness and balance over six months.

More Peripheral Neuropathies trials

Quick facts

Study typeInterventional
Ages55 Years and up
SexAll
Enrollment200 (estimated)
SponsorRxFunction Inc.
Industry-sponsored
Drugs / interventionschemotherapy
Locations6 sites (Mesa, Arizona and 5 other locations)
StatusRecruiting
StartedJune 17, 2025
Main results expectedDecember 10, 2027
Study endsJune 2028
Registry record updatedOctober 5, 2026
Trial IDNCT06959277 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 55 or older with a clinical diagnosis of chronic peripheral neuropathy (including chemo-induced PN at least one year post-chemotherapy), self-reported balance or gait problems, appropriate foot size for the device, and the ability to complete functional outcome measures without an assistive device.

Probably not a fit

People with near-normal balance (for example able to stand on one leg for 30 seconds), active acute vascular conditions like thrombophlebitis or DVT, incompatible foot size, or those who require assistive devices for testing are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, controlled comparison of daily Walkasins use versus no device across multiple U.S. clinical sites over a six-month period. Eligible participants are adults 55 and older with chronic peripheral neuropathy and self-reported balance or gait problems who can complete functional tests without an assistive device. Study procedures include baseline and periodic timed standing and walking tests, questionnaires about balance and falls, regular clinic visits and phone calls, and daily use of the Walkasins device for those assigned to it. Control-group participants are offered the device after six months, and outcomes include self-reported foot-placement awareness plus objective measures such as gait speed and functional balance tests.

Why it matters

Potential benefit: If successful, Walkasins could improve balance and gait speed and reduce fall risk in people with peripheral neuropathy.

How similar studies have gone: Prior published work, including a randomized crossover in PLOS ONE and the multi-site walk2Wellness trial, reported clinically meaningful improvements in gait speed and functional balance and reductions in fall rates with Walkasins use.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Able to understand and provide informed consent for him or herself
* Age 55 and older, male or female
* Able to complete all functional outcome measures without the use of an assistive device
* Clinical diagnosis of peripheral neuropathy prior to participating in the study as documented in the participant's medical record or by physician's note. Individuals with chemo-induced peripheral neuropathy must be at least one-year post-chemotherapy, indicating that their PN has become a chronic condition.
* Self-reported gait and balance problems
* Foot size that allows the Walkasins to function appropriately
* Willing to use the Walkasins device as recommended

Exclusion Criteria:

* Ability to stand on one leg for at least 30 seconds (If the person can stand for at least 30 seconds, he/she is excluded because his/her balance is likely not impaired enough to benefit from Walkasins.)
* Self-reported acute thrombophlebitis, including deep vein thrombosis
* Self-reported severe peripheral vascular disease
* Untreated lymphedema
* Untreated lesion of any kind, swelling, infection, inflamed area of skin or eruptions on the lower leg near product use
* Self-reported, untreated fractures in the foot and ankle
* Other neurological or musculoskeletal conditions that moderately or severely impact walking
* Use of ankle-foot orthosis for ambulation that prevents donning of Walkasins
* Weight of more than 300 pounds
* Inability to perceive vibration from Walkasins Haptic Module

Where it's running

  • Fairview Frontiers
    Saint Paul, Minnesota, United States
    Recruiting
  • Dent Neurologic Institute
    Amherst, New York, United States
    Recruiting
  • University of Pittsburgh
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • University of Texas Medical Branch
    Galveston, Texas, United States
    Recruiting
  • OrthoArizona--Mesa Arbor Avenue
    Mesa, Arizona, United States
    Active not recruiting
  • Marcus Institute for Aging Research, Hebrew SeniorLife
    Boston, Massachusetts, United States
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.